Gregory J Divis
CIK 1410677 · Chief Executive Officer · last filed 2026-02-12
Gregory J Divis is a Chief Executive Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider disposed of $4.6M of AVDL on Feb 12, 2026. Across all open-market trades the lifetime net is +$727.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $32.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.6K
3
31
$727.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Chief Executive Officer | 0 | $21.64 | $0 | $727.6K | 17 | 2026-02-12 |
| JAGX | Director | 12,133 | $2.69 | $32.6K | $0 | 6 | 2022-05-18 |
| K-V Pharmaceutical Co (KV.B) Delisted | CEO and President | 1,225 | — | — | $0 | 6 | 2012-03-30 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Disp (D) | −221,105 | -$4.64M | EDGAR |
| 2025-03-07 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +52,000 | $0 | EDGAR |
| 2024-12-10 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +10,000 | $99.7K | EDGAR |
| 2024-03-04 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-10 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +10,000 | $132.0K | EDGAR |
| 2023-06-05 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +50,000 | $102.5K | EDGAR |
| 2022-05-18 | JAGX | Exer (M) | +12,133 | $0 | EDGAR |
| 2022-03-30 | JAGX | Grant (A) | — | $0 | EDGAR |
| 2021-12-09 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |